scholarly journals Ventricular Fibrillation Arrest and Pulmonary Homograft Rupture During Transcatheter Pulmonary Valve: Successful Rescue by Heart Team

2021 ◽  
Vol 17 (2) ◽  
pp. 152-156
Author(s):  
Lameez El Nihum ◽  
Zhongyu Li ◽  
Mahesh Ramchandani ◽  
Michael Reardon ◽  
Erik Suarez ◽  
...  
Keyword(s):  
Ventricular Fibrillation ◽  
Pulmonary Valve ◽  
Adult Congenital Heart Disease ◽  
Complete Recovery ◽  
Pulmonary Valve Replacement ◽  
Team Approach ◽  
Heart Team ◽  
Surgical Interventions ◽  
Adult Congenital ◽  
Pulmonary Homograft

We describe a 31-year-old woman with pulmonary homograft rupture and ventricular fibrillation arrest complicating a transcatheter pulmonary valve (TPV) procedure. She underwent extracorporeal membrane oxygenation (ECMO) with immediate surgical repair including bioprosthetic pulmonary valve replacement. She had difficulty weaning off ECMO due to hyperacute failure of the valve and ultimately underwent successful hybrid TPV with complete recovery. This case illustrates the importance of the heart team approach during catheter and surgical interventions in adult congenital heart disease.

scholarly journals Left Main Coronary Artery Compression following Melody Pulmonary Valve Implantation: Use of Impella Support as Rescue Therapy and Perioperative Challenges with ECMO

2014 ◽  
Vol 2014 ◽  
pp. 1-3 ◽  
Author(s):  
Erica D. Wittwer ◽  
Juan N. Pulido ◽  
Shane M. Gillespie ◽  
Frank Cetta ◽  
Joseph A. Dearani
Keyword(s):  
Coronary Artery ◽  
Left Main Coronary Artery ◽  
Pulmonary Valve ◽  
Rescue Therapy ◽  
Coronary Artery Occlusion ◽  
Pulmonary Valve Replacement ◽  
Artery Occlusion ◽  
Ecmo Support ◽  
Left Main ◽  
Pulmonary Homograft

The purpose of this case is to describe the complex perioperative management of a 30-year-old woman with congenital heart disease and multiple resternotomies presenting with pulmonary homograft dysfunction and evaluation for percutaneous pulmonary valve replacement. Transvenous, transcatheter Melody valve placement caused left main coronary artery occlusion and cardiogenic shock. An Impella ventricular assist device (VAD) provided rescue therapy during operating room transport for valve removal and pulmonary homograft replacement. ECMO support was required following surgery. Several days later during an attempted ECMO wean, her hemodynamics deteriorated abruptly. Transesophageal and epicardial echocardiography identified pulmonary graft obstruction, requiring homograft revision due to large thrombosis. This case illustrates a role for Impella VAD as bridge to definitive procedure after left coronary occlusion and describes management of complex perioperative ECMO support challenges.

Postcardiotomy refractory ventricular fibrillation: rescue using veno-arterial extracorporeal membrane oxygenation

Perfusion ◽  
2017 ◽  
Vol 33 (5) ◽  
pp. 401-403
Author(s):  
Ilya Soynov ◽  
Igor Kornilov ◽  
Alexey Zubritskiy ◽  
Dmitriy Ponomarev ◽  
Nataliya Nichay ◽  
...  
Keyword(s):  
Congenital Heart Disease ◽  
Heart Disease ◽  
Ventricular Fibrillation ◽  
Extracorporeal Membrane Oxygenation ◽  
Valve Replacement ◽  
Congenital Heart ◽  
Pulmonary Valve ◽  
Pulmonary Valve Replacement ◽  
Bridge To Recovery ◽  
Membrane Oxygenation

We present a case of 7-hour ventricular fibrillation with successful use of veno-arterial extracorporeal membrane oxygenation as a bridge to recovery in a 30-year-old patient with grown-up congenital heart disease who underwent pulmonary valve replacement.

scholarly journals Adult Congenital Heart Disease Investigated with Cardiac Catheterization Over A 20-Year Period

2009 ◽  
Vol 3 (1) ◽  
pp. 124-127 ◽  
Author(s):  
George D Giannoglou ◽  
Antonios P Antoniadis ◽  
Yiannis S Chatzizisis ◽  
George E Louridas
Keyword(s):  
Congenital Heart Disease ◽  
Heart Disease ◽  
Atrial Septal Defect ◽  
Cardiac Catheterization ◽  
Congenital Heart ◽  
Septal Defect ◽  
Pulmonary Valve ◽  
Adult Congenital Heart Disease ◽  
Pulmonary Valve Stenosis ◽  
Adult Congenital

Background: Recent advances in diagnosis and treatment have increased the life expectancy of patients with congenital heart disease. Methods: To investigate the prevalence of adult congenital heart disease (ACHD) in a large registry of patients over a 20-year period, we retrospectively assessed data of 14,012 males and 4,461 females who underwent clinically indicated cardiac catheterization from 1984 to 2003. Results: ACHD was recorded in 234 subjects aged from 18 to 66 years, [95 males (40.7%) and 139 females (59.3%)]. Females were more likely to present with ACHD than males (p<0.001). Atrial septal defect was the most common defect (43.3%) followed by partial anomalous pulmonary venous return (12.0%), pulmonary valve stenosis (11.3%) ventricular septal defect (8.0%), coarctation of aorta (5.5%) patent ductus arteriosus (4.0%) and Fallot’s tetralogy (3.3%). Atrial septal defect was more common in females (p<0.01), while pulmonary valve stenosis was more frequent in males (p<0.05). No difference across sexes was found in the other forms of ACHD. Females with ACHD were significantly older than males at the time of catheterization (median age 41 years, interquartile range 26 to 53 years vs. median age 35 years, interquartile range 22 to 48 years, p<0.05). Conclusions: In adulthood ACHD is found more commonly in females and is diagnosed later in life than in males. Atrial septal defect is the most prevalent form of ACHD and occurs most commonly in females.

Adult Congenital Pulmonary Valve Replacement: A Simple, Effective, and Reproducible Technique

2007 ◽  
Vol 2 (5) ◽  
pp. 314-318 ◽  
Author(s):  
Brian E. Kogon ◽  
Katherine A. Rodby ◽  
Paul M. Kirshbom ◽  
Kirk R. Kanter ◽  
Teresa Lyle ◽  
...  
Keyword(s):  
Valve Replacement ◽  
Pulmonary Valve ◽  
Pulmonary Valve Replacement ◽  
Reproducible Technique ◽  
Adult Congenital

Ventricular Fibrillation and Myocardial Depression Following Pulmonary Valve Replacement in Tetralogy of Fallot With an Intramural Coronary Artery and Coronary Artery Compression by Chest Tube

2017 ◽  
Vol 11 (4) ◽  
pp. NP77-NP79
Author(s):  
Mubbasheer Ahmed ◽  
Nathan E. Thompson ◽  
Susan R. Foerster ◽  
Michele A. Frommelt ◽  
Michael E. Mitchell ◽  
...  
Keyword(s):  
Coronary Artery ◽  
Ventricular Fibrillation ◽  
Tetralogy Of Fallot ◽  
Valve Replacement ◽  
Chest Tube ◽  
Pulmonary Valve ◽  
Pulmonary Valve Replacement ◽  
External Compression ◽  
Coronary Insufficiency ◽  
Ventricular Dysrhythmias

We describe the case of a 10-year-old male with a history of repaired Tetralogy of Fallot and known intramural right coronary artery (RCA) who presented for bioprosthetic pulmonary valve replacement. The operation was complicated by postoperative ventricular fibrillation arrest. Selective coronary angiography revealed external compression of the mid-RCA by a mediastinal chest tube that improved immediately upon removal of the tube. Ultimately, the patient required additional unroofing of the intramural coronary for full recovery. This case highlights the need to thoroughly investigate malignant ventricular dysrhythmias following pediatric cardiac surgery and to rule out coronary insufficiency, which may be due to both extrinsic and/or intrinsic lesions.

scholarly journals Tissue Engineered Transcatheter Pulmonary Valved Stent Implantation: Current State and Future Prospect

2022 ◽  
Vol 23 (2) ◽  
pp. 723
Author(s):  
Zhang Xiling ◽  
Thomas Puehler ◽  
Jette Seiler ◽  
Stanislav N. Gorb ◽  
Janarthanan Sathananthan ◽  
...  
Keyword(s):  
Right Ventricular ◽  
Valve Replacement ◽  
Pulmonary Valve ◽  
Right Ventricular Outflow Tract ◽  
Ventricular Outflow Tract ◽  
Pulmonary Valve Replacement ◽  
Outflow Tract ◽  
Complex Congenital Heart Disease ◽  
Surgical Interventions ◽  
Transcatheter Pulmonary Valve Replacement

Patients with the complex congenital heart disease (CHD) are usually associated with right ventricular outflow tract dysfunction and typically require multiple surgical interventions during their lives to relieve the right ventricular outflow tract abnormality. Transcatheter pulmonary valve replacement was used as a non-surgical, less invasive alternative treatment for right ventricular outflow tract dysfunction and has been rapidly developing over the past years. Despite the current favorable results of transcatheter pulmonary valve replacement, many patients eligible for pulmonary valve replacement are still not candidates for transcatheter pulmonary valve replacement. Therefore, one of the significant future challenges is to expand transcatheter pulmonary valve replacement to a broader patient population. This review describes the limitations and problems of existing techniques and focuses on decellularized tissue engineering for pulmonary valve stenting.

Sign in / Sign up

Export Citation Format

Share Document